The Danaher Genomic Medicines Summit convened many of the field’s top pioneers to discuss challenges and strategies for creating a world without disea

The rapidly evolving field of genomic medicines has manufacturers scrambling to scale up the production of complex medicines. Flexibility is key.

The life sciences companies at Danaher enable gene editing, gene therapy and mRNA with integrated solutions that improve R&D and manufacturing.

The Life Sciences companies at Danaher are setting the template for mRNA medicines, with innovations in plasmid DNA, RNA oligonucleotides and more.

Here’s how synthetic biology can boost drug discovery, portable cell-free solutions for scalable manufacturing and preclinical testing methods.